VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease
- 9 May 2006
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (11-12) , 1109-1121
- https://doi.org/10.1016/j.bbadis.2006.04.005
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: Evidence from knockout mice and growth factor administrationDevelopmental Biology, 2005
- Common mechanisms of nerve and blood vessel wiringNature, 2005
- Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosisneurogenetics, 2005
- Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 ratsNeuroReport, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementiaNeurobiology of Aging, 2002
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993